Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Lise-Lotte Henningsen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.4% 2.3% 2.0% 2.1% 2.1% 2.3% 10.6% 10.6%   Credit score (0-100)   65 66 68 66 66 64 23 23   Credit rating   BBB BBB A A BBB BBB BB BB   Credit limit (kDKK)   0.1 0.1 0.6 0.4 0.4 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,265 2,221 2,300 2,533 2,085 2,721 0.0 0.0   EBITDA   1,037 943 792 892 721 1,483 0.0 0.0   EBIT   851 753 504 602 430 1,337 0.0 0.0   Pre-tax profit (PTP)   806.1 723.3 476.0 573.6 306.4 1,126.9 0.0 0.0   Net earnings   628.8 563.4 370.5 447.4 239.2 1,096.5 0.0 0.0   Pre-tax profit without non-rec. items   806 723 476 574 306 1,127 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   463 961 786 597 425 131 0.0 0.0   Shareholders equity total   4,009 3,973 4,143 4,534 4,716 5,754 5,643 5,643   Interest-bearing liabilities   0.0 0.0 267 0.0 98.2 69.3 0.0 0.0   Balance sheet total (assets)   5,447 5,056 5,241 5,441 7,662 8,549 5,643 5,643   Net Debt   -2,971 -2,208 -2,162 -2,763 -5,648 -8,127 -5,643 -5,643     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,265 2,221 2,300 2,533 2,085 2,721 0.0 0.0   Gross profit growth   -1.8% -1.9% 3.6% 10.1% -17.7% 30.5% -100.0% 0.0%   Employees   2 3 3 3 1 1 0 0   Employee growth %   0.0% 50.0% 0.0% 0.0% -66.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,447 5,056 5,241 5,441 7,662 8,549 5,643 5,643   Balance sheet change%   5.3% -7.2% 3.7% 3.8% 40.8% 11.6% -34.0% 0.0%   Added value   1,037.5 943.2 792.0 891.7 719.6 1,483.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -359 207 -562 -579 -563 -1,840 -131 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   37.6% 33.9% 21.9% 23.8% 20.6% 49.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.1% 14.4% 9.9% 11.4% 6.7% 16.5% 0.0% 0.0%   ROI %   19.1% 17.0% 10.9% 12.4% 8.7% 24.2% 0.0% 0.0%   ROE %   15.7% 14.1% 9.1% 10.3% 5.2% 20.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   73.6% 78.1% 79.1% 83.3% 61.6% 67.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -286.3% -234.1% -273.0% -309.8% -783.3% -547.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 6.4% 0.0% 2.1% 1.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 23.7% 25.0% 265.4% 254.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.3 3.9 5.1 6.5 2.2 3.1 0.0 0.0   Current Ratio   3.3 3.9 5.1 6.5 2.2 3.1 0.0 0.0   Cash and cash equivalent   2,970.7 2,208.4 2,428.8 2,762.8 5,746.4 8,196.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,206.9 1,778.1 2,291.8 2,829.6 3,238.0 5,706.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   519 314 264 297 720 1,483 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   519 314 264 297 721 1,483 0 0   EBIT / employee   426 251 168 201 430 1,337 0 0   Net earnings / employee   314 188 123 149 239 1,097 0 0